Beta Blockers May Hold Key to Unleashing Potential of Checkpoint Inhibitors, Roswell Park Team Shows


Newswise image
In new research published in the journal Cancer Research, a team from Roswell Park has shown that “beta blocker” drugs appear to be an effective means of reducing beta-2 receptor signaling and, in the process, may improve the efficacy of checkpoint inhibitor immunotherapy